.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

What's in a Name? Understanding Neuroendocrine Tumors

EP. 1: What Are Neuroendocrine Tumors?

September 2nd 2016

EP. 2: Pancreatic NETs: Michael's Story

September 2nd 2016

EP. 3: A Surgery Story: Pancreatic NETs

September 2nd 2016

EP. 4: Why You Need an Expert in NETS

September 2nd 2016

EP. 5: Living with Carcinoid Tumors

September 2nd 2016

EP. 6: Brenda's Carcinoid Tumor Diagnosis

September 2nd 2016

EP. 7: Why Carcinoid Tumors Might Be Missed

September 2nd 2016

EP. 8: What a Carcinoid Cancer Diagnosis Means

September 2nd 2016

EP. 9: NETs: The First Steps to Treatment

September 2nd 2016

EP. 10: About The Carcinoid Cancer Foundation

September 2nd 2016

EP. 11: Finding Answers to Your First Questions

September 2nd 2016

EP. 12: Reasons for Starting Treatment of NETs

September 2nd 2016

EP. 13: Pancreatic NETs: What to Ask Your Oncologist

September 2nd 2016

EP. 14: Treating Pancreatic NETs

September 2nd 2016

EP. 15: Carcinoid Tumors: What to Ask Your Oncologist

September 2nd 2016

EP. 16: Approach to Treating Carcinoid Tumors

September 2nd 2016

EP. 17: Patient Treatment Experiences

September 2nd 2016

EP. 18: NETs: A Personalized Approach

September 2nd 2016

EP. 19: The Need for Support

September 2nd 2016

EP. 20: Affording the Best Care

September 2nd 2016

Latest News

How I Eventually Gained Confidence Towards Cancer Scans

Lynparza Receives FDA Approval With Abiraterone for Treatment of Specific Patients With Prostate Cancer

FDA Accepts New Drug Application for Tyrosine Kinase Inhibitor to Treat NSCLC Subset

Hair: A Bold, Bald Statement During Cancer

View More Latest News